-
The 4th Chinese Wolfberry Industry Expo was held in the "Hometown of Chinese Wolfberry"
Time of Update: 2021-08-12
(Finish) Medicine Net, June 23 News On June 22, the 4th Goji Industry Expo was held in Zhongning County, Zhongwei City, Ningxia, which is known as the "Hometown of Chinese Goji Berries" .
-
Announcement of the State Food and Drug Administration: 16 batches of drugs are unqualified
Time of Update: 2021-08-12
Chinese herbal medicine pieces: traits (6 batches), impuritiesThe following is the original text:After inspection by 8 drug inspection institutions including Anhui Food and Drug Inspection and Research Institute, 16 batches of drugs including compound clotrimazole cream produced by 14 companies including Hebei Jiuzheng Pharmaceutical Co.
-
Many pharmaceutical companies rushed into the fifth batch of national procurement
Time of Update: 2021-08-12
Before the opening of the fifth batch of centralized procurement bids, the speed of consistency evaluation of drug companies' product varieties continued to be unabated, also in order to obtain admission tickets to the national procurement more quickly .
-
390,000 pharmacies issued by the country
Time of Update: 2021-08-12
150 billion yuan, of which the cumulative balance of employee medical insurance personal accounts was 10,096 100 million yuan .
55 million people participated in employee medical insurance nationwide, an increase of 15.
-
Sanofi Greater China restructuring
Time of Update: 2021-08-12
Specifically, starting from June 16, He Enting, the former General Manager of Sanofi Pharmaceuticals Global Business Unit in China and President of China, and Zhang Heping, General Manager of Sanofi Pasteur in China, will be responsible for the corresponding departments in Greater China.
-
The fifth batch of nationally sourced chemical injections meets challenges
Time of Update: 2021-08-12
Although since 4+7, foreign companies have taken measures such as stripping off original research drugs in response to centralized procurement, after all, the market for chemical injections is huge.
-
The State Food and Drug Administration revised the instructions for Carbimazole tablets
Time of Update: 2021-08-12
The marketing authorization holders of the above-mentioned drugs shall, in accordance with the "Administrative Measures on Drug Registration" and other relevant regulations, revise the instructions (see appendix) in accordance with the requirements of the corresponding annexes, and report to the provincial drug regulatory authority for record before September 8, 2021 .
-
The fifth batch of national sourcing 122 pharmaceutical companies "war" is imminent
Time of Update: 2021-08-12
The fifth batch of national centralized procurement that will be settled on June 23, the participation of foreign pharmaceutical companies has also brought many expectations and reveries to the industry .
-
Anti-coronavirus drug Molnupiravir: What is the prospect of Merck’s new drug?
Time of Update: 2021-08-12
Overall, the current Molnupiravir is still an experimental oral antiviral drug, which was originally a small molecule compound developed for the treatment of influenza .
" This means that commonly used antiviral drugs may have a poor final treatment effect on the new crown .
-
Generic drug development: Bolar exception to the patent system
Time of Update: 2021-08-12
Therefore, if the generic drug manufacturer can only start the development and registration application of the generic drug after the expiration of the patent right protection period, the generic drug can be truly introduced to the market after a lengthy approval process .
-
Two injections of Shutaishen have been accepted for new drug clinical trials
Time of Update: 2021-08-12
On June 21, Shutaishen announced that BDB-001 injection (ANCA-related vasculitis indication) was accepted for clinical trials of new drugs; STSA-1002 injection was accepted for clinical trials of new drugs by the US FDA .
BDB-001 Injection This application is a new indication and is intended to be used for the treatment of anti-neutrophil cytoplasmic antibody-related vasculitis .
-
Astellas announces early retirement plan, Hui causes more than 1,400 job cuts
Time of Update: 2021-08-12
According to foreign media reports, the factory will be closed at the end of next month, and 1431 employees will be dismissed.
-
US FDA approves Ryplazim: the first drug to treat plasminogen deficiency
Time of Update: 2021-08-12
While approving Ryplazim, the FDA also issued a rare pediatric disease priority review voucher (PRV) to Liminal BioSciences to reward the company for its outstanding contribution to the development of new drugs for rare diseases .
-
Zhejiang Pharmaceutical Ninofloxacin Malate Sodium Chloride Injection Obtained Drug Registration Certificate
Time of Update: 2021-08-12
On June 21, Zhejiang Medicine announced that it had recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for nanoxacin malate sodium chloride injection 250ml:0.
-
GSK/Vir Announces Final Data of Monoclonal Antibody Sotrovimab Phase 3 COMET-ICH Study
Time of Update: 2021-08-12
Recently, GlaxoSmithKline (GSK) and Vir Biotech announced the final confirmation results of the Phase 3 COMET-ICE study (COVID-19 Monoclonal Antibody Efficacy Trial-Early Care Intention), which shows: Compared with placebo , The monoclonal antibody sotrovimab (formerly known as VIR-7831, GSK4182136) intravenous infusion therapy can significantly reduce the risk of hospitalization or death in high-risk outpatients with mild to moderate COVID-19 .
-
New drug for multiple sclerosis!
Time of Update: 2021-08-12
Sanofi recently announced that the European Commission (EC) has approved the expansion of Aubagio (teriflunomide, teriflunomide) for the first-line treatment of relapsing-remitting multiple sclerosis (RRMS) pediatrics aged 10-17 years Patient .
-
The formulation of the provincial standard of Chinese medicine formula granules in Qinghai Province officially started
Time of Update: 2021-08-12
According to Zhang Zhongtian, deputy director of the Qinghai Provincial Drug Administration, in February this year, after the State Drug Administration and other four ministries and commissions issued an announcement on the end of the pilot work of traditional Chinese medicine formulation particles, the Qinghai Provincial Drug Administration immediately organized relevant companies to discuss and implement them.
-
Academicians and experts gathered in the Yangtze River Delta to support the high-quality development of the medical industry
Time of Update: 2021-08-12
One of the changes: understanding internationalization Meng Dongping, secretary of the Party Committee of the China Chamber of Commerce for Import and Export of Medicines and Health Products , said that China’s current medical and health industry, especially the medical device industry, is already at the center of the world stage.
-
Latest news from the Food and Drug Administration: The General Administration of Customs has added Changchun Air Port as a drug import port
Time of Update: 2021-08-12
Add the Jilin Provincial Drug Administration as the port drug supervision and management department, which will undertake the specific work of the record of drug imports at Changchun Airport .
Since the date of this announcement, Jilin Provincial Institute of Drug Inspection has begun to undertake the inspection of drugs at Changchun Airport .
-
FDA approves Brexafemme, the first new class of antifungal drug, Hausen owns Chinese rights
Time of Update: 2021-08-12
Recently, Synexis, a partner of Hausen Pharmaceuticals, announced that the US Food and Drug Administration has approved a new broad-spectrum antifungal drug Brexafemme, which is an oral drug for the treatment of female patients with vulvovaginal candidiasis .
